Literature DB >> 21215340

From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.

Bruce Y Lee1, Kristina M Bacon, Julie M Donohue, Ann E Wiringa, Rachel R Bailey, Richard K Zimmerman.   

Abstract

Although studies have suggested that a patient's perceived cost-benefit of a medical intervention could affect his or her utilization of the intervention, the economic value of influenza vaccine from the patient's perspective remains unclear. Therefore, we developed a stochastic decision analytic computer model representing an adult's decision of whether to get vaccinated. Different scenarios explored the impact of the patient being insured versus uninsured, influenza attack rate, vaccine administration costs and vaccination time costs. Results indicated that the cost of avoiding influenza was fairly low (with one driver being required vaccination time). To encourage vaccination, decision makers may want to focus on ways to reduce this time, such as vaccinating at work, churches, or other normally frequented locations.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21215340      PMCID: PMC3046420          DOI: 10.1016/j.vaccine.2010.12.078

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  47 in total

1.  How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.

Authors:  Yuting Zhang; Judith R Lave; Joseph P Newhouse; Julie M Donohue
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-12-14       Impact factor: 4.077

2.  Predictors of influenza vaccine acceptance among healthy adults.

Authors:  G B Chapman; E J Coups
Journal:  Prev Med       Date:  1999-10       Impact factor: 4.018

3.  Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Authors:  Anthony E Fiore; Timothy M Uyeki; Karen Broder; Lyn Finelli; Gary L Euler; James A Singleton; John K Iskander; Pascale M Wortley; David K Shay; Joseph S Bresee; Nancy J Cox
Journal:  MMWR Recomm Rep       Date:  2010-08-06

4.  Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.

Authors:  Bruce Y Lee; Rachel R Bailey; Ann E Wiringa; Tina-Marie Assi; Richard H Beigi
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

5.  Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Authors:  Eric Plennevaux; Eric Sheldon; Mark Blatter; Mary-Kate Reeves-Hoché; Martine Denis
Journal:  Lancet       Date:  2009-12-15       Impact factor: 79.321

6.  The 2009 H1N1 pandemic influenza virus: what next?

Authors:  David M Morens; Jeffery K Taubenberger; Anthony S Fauci
Journal:  MBio       Date:  2010-09-28       Impact factor: 7.867

7.  The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.

Authors:  Anne M Presanis; Daniela De Angelis; Angela Hagy; Carrie Reed; Steven Riley; Ben S Cooper; Lyn Finelli; Paul Biedrzycki; Marc Lipsitch
Journal:  PLoS Med       Date:  2009-12-08       Impact factor: 11.069

Review 8.  Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles.

Authors:  Bruce Y Lee; Donald S Burke
Journal:  Vaccine       Date:  2009-09-25       Impact factor: 3.641

9.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Authors:  Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon
Journal:  Lancet       Date:  2010-01-21       Impact factor: 79.321

10.  Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009.

Authors:  Carrie Reed; Frederick J Angulo; David L Swerdlow; Marc Lipsitch; Martin I Meltzer; Daniel Jernigan; Lyn Finelli
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more
  17 in total

1.  Association of Influenza Vaccination Coverage in Younger Adults With Influenza-Related Illness in the Elderly.

Authors:  Glen B Taksler; Michael B Rothberg; David M Cutler
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

2.  The cost of an Ebola case.

Authors:  Sarah M Bartsch; Katrin Gorham; Bruce Y Lee
Journal:  Pathog Glob Health       Date:  2015-01-11       Impact factor: 2.894

3.  Cost-effectiveness of adult vaccinations: A systematic review.

Authors:  Andrew J Leidner; Neil Murthy; Harrell W Chesson; Matthew Biggerstaff; Charles Stoecker; Aaron M Harris; Anna Acosta; Kathleen Dooling; Carolyn B Bridges
Journal:  Vaccine       Date:  2018-12-04       Impact factor: 3.641

4.  Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs.

Authors:  Yoko Ibuka; A David Paltiel; Alison P Galvani
Journal:  Med Decis Making       Date:  2012-04-03       Impact factor: 2.583

5.  The potential economic value of a human norovirus vaccine for the United States.

Authors:  Sarah M Bartsch; Benjamin A Lopman; Aron J Hall; Umesh D Parashar; Bruce Y Lee
Journal:  Vaccine       Date:  2012-09-28       Impact factor: 3.641

6.  School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program.

Authors:  Ricardo Basurto-Dávila; Martin I Meltzer; Dora A Mills; Garrett R Beeler Asay; Bo-Hyun Cho; Samuel B Graitcer; Nancy L Dube; Mark G Thompson; Suchita A Patel; Samuel K Peasah; Jill M Ferdinands; Paul Gargiullo; Mark Messonnier; David K Shay
Journal:  Health Serv Res       Date:  2017-12       Impact factor: 3.402

7.  The benefits to all of ensuring equal and timely access to influenza vaccines in poor communities.

Authors:  Bruce Y Lee; Shawn T Brown; Rachel R Bailey; Richard K Zimmerman; Margaret A Potter; Sarah M McGlone; Philip C Cooley; John J Grefenstette; Shanta M Zimmer; William D Wheaton; Sandra Crouse Quinn; Ronald E Voorhees; Donald S Burke
Journal:  Health Aff (Millwood)       Date:  2011-06       Impact factor: 6.301

8.  Quantifying the economic value and quality of life impact of earlier influenza vaccination.

Authors:  Bruce Y Lee; Sarah M Bartsch; Shawn T Brown; Philip Cooley; William D Wheaton; Richard K Zimmerman
Journal:  Med Care       Date:  2015-03       Impact factor: 2.983

9.  Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.

Authors:  Mohamed A Kamal; Patrick F Smith; Nathorn Chaiyakunapruk; David B C Wu; Chayanin Pratoomsoot; Kenneth K C Lee; Huey Yi Chong; Richard E Nelson; Keith Nieforth; Georgina Dall; Stephen Toovey; David C M Kong; Aaron Kamauu; Carl M Kirkpatrick; Craig R Rayner
Journal:  Br J Clin Pharmacol       Date:  2017-02-20       Impact factor: 4.335

10.  An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.

Authors:  Bruce Y Lee; Sarah M Bartsch; Mercy Mvundura; Courtney Jarrahian; Kristina M Zapf; Kathleen Marinan; Angela R Wateska; Bill Snyder; Savitha Swaminathan; Erica Jacoby; James J Norman; Mark R Prausnitz; Darin Zehrung
Journal:  Vaccine       Date:  2015-03-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.